MDPI and ACS Style
Nguyen, L.P.; Park, C.S.; Pinto, N.A.; Lee, H.; Seo, H.S.; Vu, T.N.; Mai, H.; Pham, A.H.T.; Jang, E.; Cho, Y.L.;
et al. In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea. Pharmaceuticals 2021, 14, 370.
https://doi.org/10.3390/ph14040370
AMA Style
Nguyen LP, Park CS, Pinto NA, Lee H, Seo HS, Vu TN, Mai H, Pham AHT, Jang E, Cho YL,
et al. In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea. Pharmaceuticals. 2021; 14(4):370.
https://doi.org/10.3390/ph14040370
Chicago/Turabian Style
Nguyen, Le Phuong, Chul Soon Park, Naina Adren Pinto, Hyunsook Lee, Hyun Soo Seo, Thao Nguyen Vu, Hung Mai, An H. T. Pham, Eris Jang, Young Lag Cho,
and et al. 2021. "In Vitro Activity of a Novel Siderophore-Cephalosporin LCB10-0200 (GT-1), and LCB10-0200/Avibactam, against Carbapenem-Resistant Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa Strains at a Tertiary Hospital in Korea" Pharmaceuticals 14, no. 4: 370.
https://doi.org/10.3390/ph14040370